Skip to content

efficacy of magnesium in head injury

efficacy of magnesium in outcome of head trauma patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012103111334N1
Enrollment
84
Registered
2013-08-28
Start date
2012-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head Trauma. Intracranial injury, unspecified

Interventions

Intervention 1: intervention series are patient that receive magnesium sulfate at first 8 hour of admission (as the bolus)and a course of 4 days (infusion). Intervention 2: control patients receive pl
Treatment - Drugs
intervention series are patient that receive magnesium sulfate at first 8 hour of admission (as the bolus)and a course of 4 days (infusion).
control patients receive placebo (normal saline)that are as same as magnesium vials

Sponsors

Kashan University of medical Sciences,Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: patient with GCS 3-12; cases of neurosurgical operation exclusion criteria: cr>2;pregnancy;mentally retard and psychotic patients;cases that cannot be follow up

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Prognosis of head trauma patient. Timepoint: 3d,1m and at least 3m. Method of measurement: criteria EGOS ,Karnovskey ,WISC 2.

Secondary

MeasureTime frame
Respiratory disorder by magnesium. Timepoint: Daily till 5 day. Method of measurement: Pulseoximetry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRezvani Mohammad Tagi

Kashan University of Medical Science

hamidkhayat@yahoo.com+98 36 1555 0026

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026